Influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 mL Prefilled Syringe
RxNorm 2746464
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2746464 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.5 mL influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 mg/ML Prefilled Syringe
(Atom ID: 13062248)
PSNPrescribable
Prescribable Name (PSN):
Influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 mL Prefilled Syringe
(Atom ID: 13062259)
SYPrescribable